[ASAP] Preclinical Evaluation of a Radiolabeled Pan-RAF Inhibitor for RAF-Specific PET/CT Imaging 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00649 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
